Compounds > cyclosporine

cyclosporine and Left Ventricular Dysfunction

cyclosporine has been researched along with Left Ventricular Dysfunction in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (50.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baccouch, R; Lancel, S; Marchetti, P; Marechal, X; Modine, T; Montaigne, D; Neviere, R; Preau, S; Zannis, K1
Arjun, S; Davidson, SM; Hausenloy, DJ; Lim, SY; Lythgoe, MF; Price, AN; Yellon, DM1
Akutagawa, T; Furukawa, T; Hasada, K; Hotta, Y; Mitsui-Saitoh, K; Mizutani, H; Niwa, M; Sugimoto, Y; Takaya, Y; Yamada, J1
Drafts, BC; Dubose, TD; Sutton, BJ; Thohan, V1
Bax, JJ; de Fijter, JW; Delgado, V; Ewe, SH; Mallat, MJ; Mourer, JS; Ng, AC; Rabelink, TJ1
Bassano, C; Bevilacqua, M; Boldrini, R; Bottazzo, GF; Camassei, FD; Fierabracci, A; Gagliardi, MG; Leonardi, B; Ugazio, AG1
Imai, M; Sabbah, HN; Sharov, VG; Todor, AV1
Derumeaux, G; Dumont, JM; Gharib, A; Gomez, L; Ovize, M; Scalfaro, P; Thibault, H; Vuagniaux, G1
Aoyama, T; Esaki, M; Fujiwara, H; Fujiwara, T; Kanamori, H; Kawasaki, M; Maruyama, R; Minatoguchi, S; Miyata, S; Nakagawa, M; Ogino, A; Okada, H; Takemura, G; Ushikoshi, H1
Chang, DM; Chen, CH; Ho, TY; Kuo, SY; Lai, JH; Lin, KM; Yang, DH1

Trials

1 trial(s) available for cyclosporine and Left Ventricular Dysfunction

ArticleYear
Late calcineurin inhibitor withdrawal prevents progressive left ventricular diastolic dysfunction in renal transplant recipients.
    Transplantation, 2012, Oct-15, Volume: 94, Issue:7

    Topics: Adult; Antihypertensive Agents; Blood Pressure; Calcineurin Inhibitors; Chi-Square Distribution; Cyclosporine; Diastole; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography, Doppler, Pulsed; Female; Heart Atria; Humans; Immunosuppressive Agents; Kidney Transplantation; Linear Models; Male; Middle Aged; Mitral Valve; Mycophenolic Acid; Netherlands; Predictive Value of Tests; Prednisone; Prospective Studies; Tacrolimus; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left

2012

Other Studies

9 other study(ies) available for cyclosporine and Left Ventricular Dysfunction

ArticleYear
Stabilization of mitochondrial membrane potential prevents doxorubicin-induced cardiotoxicity in isolated rat heart.
    Toxicology and applied pharmacology, 2010, May-01, Volume: 244, Issue:3

    Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Cardiotoxins; Cyclosporine; Doxorubicin; Electron Transport Complex IV; Fluorescence; Fluorometry; Heart; In Vitro Techniques; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Myocardium; Oxidative Stress; Permeability; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction, Left

2010
Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure.
    Journal of cellular and molecular medicine, 2011, Volume: 15, Issue:11

    Topics: Animals; Apoptosis; Cell Proliferation; Cyclophilins; Cyclosporine; Heart Failure; Heart Ventricles; Lactones; Male; Mice; Mice, Knockout; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Peptidyl-Prolyl Isomerase F; Spiro Compounds; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

2011
Protective effects of cyclo(L-Leu-L-Tyr) against postischemic myocardial dysfunction in guinea-pig hearts.
    Biological & pharmaceutical bulletin, 2011, Volume: 34, Issue:3

    Topics: Adenosine Triphosphate; Animals; Antioxidants; Apoptosis; Calcium; Cardiovascular Agents; Caspase 3; Cyclosporine; Dipeptides; Female; Guinea Pigs; Male; Mitochondria; Mitochondrial Membrane Transport Proteins; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Peptides, Cyclic; Structure-Activity Relationship; Ventricular Dysfunction, Left

2011
Incessant ventricular tachycardia and cardiogenic shock: a common presentation of an uncommon diagnosis.
    The American journal of the medical sciences, 2011, Volume: 342, Issue:6

    Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Blood Chemical Analysis; Cardiac Catheterization; Coronary Angiography; Cyclosporine; Diagnosis, Differential; Electrocardiography; Giant Cells; Heart; Heart Ventricles; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Myocarditis; Myocardium; North Carolina; Prednisone; Shock, Cardiogenic; Tachycardia, Ventricular; Treatment Outcome; Ventricular Dysfunction, Left

2011
Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy.
    Heart (British Cardiac Society), 2004, Volume: 90, Issue:10

    Topics: Analysis of Variance; Biopsy; Cardiomyopathy, Dilated; Child, Preschool; Cyclosporine; Endocardium; Female; Follow-Up Studies; Heart Failure; Humans; Immunosuppressive Agents; Infant; Male; Myocarditis; Prednisone; Ventricular Dysfunction, Left

2004
Inhibition of mitochondrial permeability transition pores by cyclosporine A improves cytochrome C oxidase function and increases rate of ATP synthesis in failing cardiomyocytes.
    Heart failure reviews, 2005, Volume: 10, Issue:4

    Topics: Adenosine Triphosphate; Animals; Cell Respiration; Chronic Disease; Cyclosporine; Disease Models, Animal; Dogs; Electron Transport Complex IV; Enzyme Inhibitors; Heart Failure; Heart Ventricles; Membrane Potentials; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardium; Myocytes, Cardiac; Ventricular Dysfunction, Left

2005
Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:3

    Topics: Acute Disease; Animals; Calcium; Cyclosporine; Disease Models, Animal; Ischemic Preconditioning, Myocardial; Male; Mice; Mitochondria, Heart; Myocardial Infarction; Permeability; Reperfusion Injury; Survival Analysis; Ventricular Dysfunction, Left

2007
Amlodipine inhibits granulation tissue cell apoptosis through reducing calcineurin activity to attenuate postinfarction cardiac remodeling.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:4

    Topics: Amlodipine; Animals; Apoptosis; bcl-Associated Death Protein; Calcineurin; Calcineurin Inhibitors; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Coronary Vessels; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; fas Receptor; Granulation Tissue; Hydralazine; Ligation; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Phosphorylation; Research Design; Tacrolimus; Time Factors; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

2007
Etanercept as a rescue agent in patient with adult onset Still's disease complicated with congestive heart failure.
    Rheumatology international, 2008, Volume: 29, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Ferritins; Glucocorticoids; Heart Failure; Humans; Immunoglobulin G; Immunosuppressive Agents; Myocarditis; Radiography, Thoracic; Receptors, Tumor Necrosis Factor; Recovery of Function; Still's Disease, Adult-Onset; Treatment Outcome; Ventricular Dysfunction, Left; Young Adult

2008